Last 12 months
Inside the activity.
22 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 6 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 10 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 6 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2020 Filed May 15, 2020 22:10 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock Options · Derivative | 25,000 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001209191-20-029842 · doc4.xml · derivative · entry 3 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2025-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2020 Filed May 15, 2020 22:10 UTC |
Holliday KeithChief Technology Officer
|
SaleCommon Stock | 25,000 | $37.69 | $942,250.00 |
DisclosureSEC source: 0001209191-20-029842 · doc4.xml · nonDerivative · entry 2 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,447 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.52 to $37.88, inclusive. Read SEC document |
| May 15, 2020 Filed May 15, 2020 22:10 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock | 25,000 | $7.20 | $180,000.00 |
DisclosureSEC source: 0001209191-20-029842 · doc4.xml · nonDerivative · entry 1 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2020 Filed May 13, 2020 22:49 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock Options · Derivative | 6,667 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001209191-20-028979 · doc4.xml · derivative · entry 7 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,333 Underlying: Common Stock · 6,667 shares Expires 2023-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2020 Filed May 13, 2020 22:49 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock | 6,667 | $5.34 | $35,601.78 |
DisclosureSEC source: 0001209191-20-028979 · doc4.xml · nonDerivative · entry 4 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,133 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:50 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
GrantCommon Stock Options · Derivative | 6,091 | $0.00 Strike: $8.64 | $0.00 |
DisclosureSEC source: 0001209191-20-028980 · doc4.xml · derivative · entry 7 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,574 Underlying: Common Stock · 6,091 shares Expires 2025-07-26 Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:50 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
GrantCommon Stock Options · Derivative | 19,178 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001209191-20-028980 · doc4.xml · derivative · entry 6 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,822 Underlying: Common Stock · 19,178 shares Expires 2026-03-17 Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:50 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
GrantCommon Stock Options · Derivative | 21,294 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001209191-20-028980 · doc4.xml · derivative · entry 5 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,206 Underlying: Common Stock · 21,294 shares Expires 2027-03-20 Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:50 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
SaleCommon Stock | 46,563 | $39.11 | $1,821,078.93 |
DisclosureSEC source: 0001209191-20-028980 · doc4.xml · nonDerivative · entry 4 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,794 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.89 to $39.10, inclusive. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:50 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock | 6,091 | $8.64 | $52,626.24 |
DisclosureSEC source: 0001209191-20-028980 · doc4.xml · nonDerivative · entry 3 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,357 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:50 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock | 19,178 | $7.52 | $144,218.56 |
DisclosureSEC source: 0001209191-20-028980 · doc4.xml · nonDerivative · entry 2 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:50 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock | 21,294 | $9.30 | $198,034.20 |
DisclosureSEC source: 0001209191-20-028980 · doc4.xml · nonDerivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:49 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock Options · Derivative | 10,856 | $0.00 Strike: $15.54 | $0.00 |
DisclosureSEC source: 0001209191-20-028979 · doc4.xml · derivative · entry 6 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,144 Underlying: Common Stock · 10,856 shares Expires 2024-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:49 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock Options · Derivative | 8,000 | $0.00 Strike: $7.35 | $0.00 |
DisclosureSEC source: 0001209191-20-028979 · doc4.xml · derivative · entry 5 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 8,000 shares Expires 2025-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:49 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
SaleCommon Stock | 18,856 | $39.06 | $736,515.36 |
DisclosureSEC source: 0001209191-20-028979 · doc4.xml · nonDerivative · entry 3 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,466 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.10, inclusive. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:49 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock | 10,856 | $15.54 | $168,702.24 |
DisclosureSEC source: 0001209191-20-028979 · doc4.xml · nonDerivative · entry 2 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:49 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock | 8,000 | $7.35 | $58,800.00 |
DisclosureSEC source: 0001209191-20-028979 · doc4.xml · nonDerivative · entry 1 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,466 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:48 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock Options · Derivative | 8,680 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-20-028977 · doc4.xml · derivative · entry 10 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,820 Underlying: Common Stock · 8,680 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:48 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock Options · Derivative | 4,862 | $0.00 Strike: $15.25 | $0.00 |
DisclosureSEC source: 0001209191-20-028977 · doc4.xml · derivative · entry 9 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,431 Underlying: Common Stock · 4,862 shares Expires 2027-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:48 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock Options · Derivative | 6,741 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001209191-20-028977 · doc4.xml · derivative · entry 8 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,741 shares Expires 2027-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:48 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
SaleCommon Stock | 8,419 | $39.01 | $328,425.19 |
DisclosureSEC source: 0001209191-20-028977 · doc4.xml · nonDerivative · entry 7 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,553 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.03, inclusive. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:48 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock | 8,680 | $16.15 | $140,182.00 |
DisclosureSEC source: 0001209191-20-028977 · doc4.xml · nonDerivative · entry 6 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:48 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
SaleCommon Stock | 3,473 | $39.02 | $135,516.46 |
DisclosureSEC source: 0001209191-20-028977 · doc4.xml · nonDerivative · entry 5 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,292 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.03, inclusive. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:48 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock | 4,862 | $15.25 | $74,145.50 |
DisclosureSEC source: 0001209191-20-028977 · doc4.xml · nonDerivative · entry 4 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:48 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
SaleCommon Stock | 2,860 | $39.04 | $111,654.40 |
DisclosureSEC source: 0001209191-20-028977 · doc4.xml · nonDerivative · entry 3 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,903 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.01 to $39.06, inclusive. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:48 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock | 6,741 | $9.30 | $62,691.30 |
DisclosureSEC source: 0001209191-20-028977 · doc4.xml · nonDerivative · entry 2 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:48 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
SaleCommon Stock | 3,437 | $39.02 | $134,111.74 |
DisclosureSEC source: 0001209191-20-028977 · doc4.xml · nonDerivative · entry 1 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,022 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.03, inclusive. Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 20:18 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
SaleCommon Stock | 2,813 | $26.83 | $75,472.79 |
DisclosureSEC source: 0001209191-20-020928 · doc4.xml · nonDerivative · entry 2 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,794 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.07 to $27.49, inclusive. Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 20:16 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
SaleCommon Stock | 2,813 | $27.42 | $77,132.46 |
DisclosureSEC source: 0001209191-20-020924 · doc4.xml · nonDerivative · entry 1 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,459 Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 20:14 UTC |
Gesten Samuel JChief Legal Officer
|
SaleCommon Stock | 2,742 | $27.42 | $75,185.64 |
DisclosureSEC source: 0001209191-20-020922 · doc4.xml · nonDerivative · entry 2 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,185 Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 20:13 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
SaleCommon Stock | 2,250 | $26.77 | $60,232.50 |
DisclosureSEC source: 0001209191-20-020917 · doc4.xml · nonDerivative · entry 2 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,466 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $27.49, inclusive. Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 20:09 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
SaleCommon Stock | 834 | $27.42 | $22,868.28 |
DisclosureSEC source: 0001209191-20-020910 · doc4.xml · nonDerivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,267 Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:12 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
GrantCommon Stock Options · Derivative | 31,979 | $0.00 Strike: $27.53 | $0.00 |
DisclosureSEC source: 0001209191-20-020915 · doc4.xml · derivative · entry 1 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,979 Underlying: Common Stock · 31,979 shares Expires 2030-03-19 F1 · security: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:19 UTC |
Holliday KeithChief Technology Officer
|
GrantCommon Stock Options · Derivative | 16,372 | $0.00 Strike: $27.53 | $0.00 |
DisclosureSEC source: 0001209191-20-020930 · doc4.xml · derivative · entry 2 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,372 Underlying: Common Stock · 16,372 shares Expires 2030-03-19 F2 · security: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:19 UTC |
Holliday KeithChief Technology Officer
|
GrantCommon Stock | 7,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020930 · doc4.xml · nonDerivative · entry 1 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,447 F1 · security: Award of 7874 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/20/21, 1/3 of the RSUs on 3/20/22, and the remaining 1/3 of the RSUs on 3/20/23. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:21 UTC |
Mason Caren LDirector · President & CEO
|
GrantCommon Stock Options · Derivative | 41,885 | $0.00 Strike: $31.66 | $0.00 |
DisclosureSEC source: 0001209191-20-020932 · doc4.xml · derivative · entry 2 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,885 Underlying: Common Stock · 41,885 shares Expires 2030-03-19 F1 · security: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:21 UTC |
Mason Caren LDirector · President & CEO
|
GrantCommon Stock Options · Derivative | 96,335 | $0.00 Strike: $27.53 | $0.00 |
DisclosureSEC source: 0001209191-20-020932 · doc4.xml · derivative · entry 1 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,335 Underlying: Common Stock · 96,335 shares Expires 2030-03-19 F1 · security: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:18 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
GrantCommon Stock Options · Derivative | 15,297 | $0.00 Strike: $27.53 | $0.00 |
DisclosureSEC source: 0001209191-20-020928 · doc4.xml · derivative · entry 3 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,297 Underlying: Common Stock · 15,297 shares Expires 2030-03-19 F3 · security: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:18 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
GrantCommon Stock | 7,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020928 · doc4.xml · nonDerivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,607 F1 · security: Award of 7357 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/20/21, 1/3 of the RSUs on 3/20/22, and the remaining 1/3 of the RSUs on 3/20/23. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:16 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
GrantCommon Stock Options · Derivative | 27,762 | $0.00 Strike: $27.53 | $0.00 |
DisclosureSEC source: 0001209191-20-020924 · doc4.xml · derivative · entry 2 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,762 Underlying: Common Stock · 27,762 shares Expires 2030-03-19 F1 · security: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:14 UTC |
Gesten Samuel JChief Legal Officer
|
GrantCommon Stock Options · Derivative | 16,102 | $0.00 Strike: $27.53 | $0.00 |
DisclosureSEC source: 0001209191-20-020922 · doc4.xml · derivative · entry 3 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,102 Underlying: Common Stock · 16,102 shares Expires 2030-03-19 F2 · security: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:14 UTC |
Gesten Samuel JChief Legal Officer
|
GrantCommon Stock | 7,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020922 · doc4.xml · nonDerivative · entry 1 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,873 F1 · price: Award of 7745 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/20/21, 1/3 of the RSUs on 3/20/22, and the remaining 1/3 of the RSUs on 3/20/23. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:13 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
GrantCommon Stock Options · Derivative | 14,374 | $0.00 Strike: $27.53 | $0.00 |
DisclosureSEC source: 0001209191-20-020917 · doc4.xml · derivative · entry 3 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,374 Underlying: Common Stock · 14,374 shares Expires 2030-03-19 F3 · security: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:13 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
GrantCommon Stock | 6,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020917 · doc4.xml · nonDerivative · entry 1 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,716 F1 · security: Award of 6913 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/20/21, 1/3 of the RSUs on 3/20/22, and the remaining 1/3 of the RSUs on 3/20/23. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:11 UTC |
Barnes Scott DChief Medical Officer
|
GrantCommon Stock Options · Derivative | 19,457 | $0.00 Strike: $27.53 | $0.00 |
DisclosureSEC source: 0001209191-20-020913 · doc4.xml · derivative · entry 2 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,457 Underlying: Common Stock · 19,457 shares Expires 2030-03-19 F2 · security: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:11 UTC |
Barnes Scott DChief Medical Officer
|
GrantCommon Stock | 9,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020913 · doc4.xml · nonDerivative · entry 1 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,390 F1 · security: Award of 9358 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/20/21, 1/3 of the RSUs on 3/20/22, and the remaining 1/3 of the RSUs on 3/20/23. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 20:15 UTC |
Moore John CDirector
|
Exercise / conversionCommon Stock Options · Derivative | 10,000 | $0.00 Strike: $5.81 | $0.00 |
DisclosureSEC source: 0001209191-20-020257 · doc4.xml · derivative · entry 3 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2021-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 20:15 UTC |
Moore John CDirector
|
Exercise / conversionCommon Stock | 10,000 | $5.81 | $58,100.00 |
DisclosureSEC source: 0001209191-20-020257 · doc4.xml · nonDerivative · entry 1 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock Options · Derivative | 3,370 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 19 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188 Underlying: Common Stock · 3,370 shares Expires 2021-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 06/14/2019, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 06/14/2021. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock Options · Derivative | 7,291 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 18 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347 Underlying: Common Stock · 7,291 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 03/15/2019, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 03/15/2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.